140
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Investigations on Acinetophage, QAB 3.4, Targeting Extensively Drug-Resistant Acinetobacter baumannii Isolates

, , , , , , , ORCID Icon, , , , , & show all
Pages 4261-4269 | Published online: 15 Oct 2021

References

  • Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484. doi:10.1128/AAC.01464-0617646423
  • Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • Popova AV, Zhilenkov EL, Myakinina VP, Krasilnikova VM, Volozhantsev NV. Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiol Lett. 2012;332(1):40–46. doi:10.1111/j.1574-6968.2012.02573.x22506502
  • Baptista PV, McCusker MP, Carvalho A, et al. Nano-strategies to fight multidrug resistant bacteria—“A battle of the titans.”. Front Microbiol. 2018;9:1441. doi:10.3389/fmicb.2018.0144130013539
  • Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10). doi:10.1099/mgen.0.000306
  • Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007;59(4):772–774. doi:10.1093/jac/dkm01817353223
  • Al-Kadmy IMS, Ibrahim SA, Al-Saryi N, Aziz SN, Besinis A, Hetta HF. Prevalence of genes involved in colistin resistance in Acinetobacter baumannii: first report from Iraq. Microb Drug Resist. 2020;26(6):616–622. doi:10.1089/mdr.2019.024331816255
  • Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012;67(7):1607–1615. doi:10.1093/jac/dks08422441575
  • Lin N-T, Chiou P-Y, Chang K-C, Chen L-K, Lai M-J. Isolation and characterization of ϕAB2: a novel bacteriophage of Acinetobacter baumannii. Res Microbiol. 2010;161(4):308–314. doi:10.1016/j.resmic.2010.03.00720385229
  • Yang H, Liang L, Lin S, Jia S. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 2010;10(1):131. doi:10.1186/1471-2180-10-13120426877
  • Regeimbal JM, Jacobs AC, Corey BW, et al. Personalized therapeutic cocktail of wild environmental phages rescues mice from Acinetobacter baumannii wound infections. Antimicrob Agents Chemother. 2016;60(10):5806–5816. doi:10.1128/AAC.02877-1527431214
  • Taj Z, Rasool MH, Almatroudi A, Saqalein M, Khurshid M. Extensively drug-resistant Acinetobacter baumannii belonging to international clone II from a pet cat with urinary tract infection; The first report from Pakistan. Pol J Microbiol. 2020;69(2):231–234. doi:10.33073/pjm-2020-017
  • Beale GH. A method for the measurement of mutation rate from phage sensitivity to phage resistance in Escherichia coli. J Gen Microbiol. 1948;2(2):131–142. doi:10.1099/00221287-2-2-131
  • Lee C-R, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7. doi:10.3389/fcimb.2017.00055
  • Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36(7):1938–1941. doi:10.1128/JCM.36.7.1938-1941.19989650940
  • Ross A, Ward S, Hyman P. More is better: selecting for broad host range bacteriophages. Front Microbiol. 2016;7:1352. doi:10.3389/fmicb.2016.0135227660623
  • Kaliste E, editor. The Welfare of Laboratory Animals. Springer Netherlands; 2007. doi:10.1007/978-1-4020-2271-5